According to the report, after the application of 39,599 doses of the coronavirus vaccine in 22 of the 24 jurisdictions From Argentina, 1,088 cases of presumed reactions to inoculation, moderate or mild, were reported practically in their entirety.
“He 39,7% of the ESAVIs reported correspond to people with fever, headache, and / or myalgia onset 6 to 8 hours later of vaccination “, indicates the report, which remarks that” 99.3% of the events reported were mild and moderate. “
According to the report, 31,1% of the events after the application of the coronavirus vaccine were headaches and myalgias; 10.2% fever; 7,2% a local reaction at the injection site and 1.3% fever with gastrointestinal symptoms. Solo 1,2% presented mild allergies; 0.6% lipotimia, as well as gastrointestinal symptoms and 0.2% drowsiness.
For people who received the coronavirus vaccine, it is recommended to consult the nearest health center in case symptoms appear after inoculation. It was also reported that, although vaccination is contraindicated in lactating women, its administration should not imply suspension.
Regarding the evaluation of vaccinated people who report symptoms after the application of the dose, the report recommends “carrying out a complete clinical evaluation, reporting the case as ESAVI”.
“Upon detection of symptoms such as fever, headache or flu-like onset within 24 to 48 hours after vaccination, it is recommended to indicate symptomatic treatment with paracetamol with home rest and isolation”the report holds.
“For the second dose, in the cases that presented mild and moderate ESAVI, it is indicated that these people should complete the vaccination schedule with a minimum interval of 21 days”, adds the report.
Florencia Bruggesser, member of the board of directors of the Argentine Society of Vaccination and Epidemiology (SAVE), said in dialogue with Telam that mild and moderate reactions occur “in almost all vaccines” and that emphasis is now being placed on “reporting any symptoms that appear after vaccination such as fever or headache” and “any event that is not associated that temporarily coincides” with inoculation.
“If a person had an accident or fainted, they are notified to see if it has to do with vaccination; It is being studied whether it is associated with the vaccine, “he explained, adding that” when it is a new vaccine, everything is analyzed, “so an exhaustive surveillance is being conducted.